BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33046048
Number of visits today
6639
Number of downloads
16241658
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yang YY, Xie L, Zhang NP, Zhou D, Liu TT, Wu J. Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis. Acta Pharmacol Sin 2022;43:1180-90. [PMID: 35190696 DOI: 10.1038/s41401-022-00860-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang GY, Zhang XY, Wang CJ, Guan YF. Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies. World J Gastroenterol 2023; 29(1): 75-95 [PMID: 36683713 DOI: 10.3748/wjg.v29.i1.75] [Reference Citation Analysis]
2 Grapentine S, Agarwal P, Dolinsky V, Bakovic M. Phosphoethanolamine reverses aberrant DNA methylation in non-alcoholic steatohepatitis caused by Pcyt2 deficiency.. [DOI: 10.21203/rs.3.rs-2143064/v1] [Reference Citation Analysis]
3 Liu F, Wei L, Leow WQ, Liu S, Ren Y, Wang X, Li X, Rao H, Huang R, Wu N, Wee A, Zhao J. Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis. Front Med 2022;9:925357. [DOI: 10.3389/fmed.2022.925357] [Reference Citation Analysis]
4 Alshehade S, Alshawsh MA, Murugaiyah V, Asif M, Alshehade O, Almoustafa H, Al Zarzour RH. The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions. Life Sci 2022;:120732. [PMID: 35760093 DOI: 10.1016/j.lfs.2022.120732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu HE, Guo JS. All about NASH: disease biology, targets, and opportunities on the road to NASH drugs. Acta Pharmacol Sin 2022;43:1101-2. [PMID: 35379932 DOI: 10.1038/s41401-022-00900-y] [Reference Citation Analysis]
6 Cabiati M, Gaggini M, De Simone P, Del Ry S. Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression. Clin Exp Metastasis 2022. [PMID: 35429302 DOI: 10.1007/s10585-022-10164-9] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345